SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-17-006393
Filing Date
2017-10-30
Accepted
2017-10-30 16:01:06
Documents
55
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_103017.htm 10-K/A 718410
2 EXHIBIT 23.1 exh_231.htm EX-23.1 3259
3 EXHIBIT 31.1 exh_311.htm EX-31.1 8070
4 EXHIBIT 31.2 exh_312.htm EX-31.2 8222
5 EXHIBIT 32.1 exh_321.htm EX-32.1 5558
  Complete submission text file 0001171843-17-006393.txt   3497861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE caps-20161231.xml EX-101.INS 541733
7 XBRL SCHEMA FILE caps-20161231.xsd EX-101.SCH 35411
8 XBRL CALCULATION FILE caps-20161231_cal.xml EX-101.CAL 29713
9 XBRL DEFINITION FILE caps-20161231_def.xml EX-101.DEF 217681
10 XBRL LABEL FILE caps-20161231_lab.xml EX-101.LAB 260349
11 XBRL PRESENTATION FILE caps-20161231_pre.xml EX-101.PRE 256275
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21214 | Film No.: 171162295
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1